Clinical trials of the first drugs designed with the help of artificial intelligence could commence this year, Google ...

In a special episode of The Conversation Weekly podcast to start 2025, we’ve brought together three science editors from The ...

Google Deepmind co-founder Demis Hassabis talks to FT editor Roula Khalaf about the real world healthcare applications of AI and how his ground-breaking work on the structure of proteins could acceler ...

Google parent Alphabet has drawn on its DeepMind artificial intelligence ... and earlier this year a new version – AlphaFold2 – was made freely available to researchers around the world.

The latest version of Google DeepMind and Isomorphic Labs’ AlphaFold ... it was improved upon with the launch of AlphaFold 2 in 2022, an update that extended the range of proteins covered ...

This new approach, based on natural selection, dramatically improves the reliability of large language models for practical ...

Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year.

Google challenges OpenAI with free Gemini 2.0 Flash Thinking model, offering million-token processing, native code execution, and breakthrough performance in math and science benchmarks.

Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups ...

Isomorphic was spun out of Google’s AI research arm Google DeepMind in 2021, but remains a wholly owned subsidiary of its parent company, Alphabet. The start-up’s potential has attracted big ...

With "Mind Evolution" LLMs can use search and genetic algorithms to generate and combine different solutions and find the optimal one.